Journal article
Decrements in health‐related quality of life associated with adverse events in people with diabetes
- Abstract:
- Aim People with diabetes are at elevated risk of adverse events due to the disease and treatments. We estimate the decrements in health-related quality of life (QoL) associated with a range of adverse events. This will inform assessments of the effects of diabetes treatments on QoL in contemporary clinical practice. Methods Participants’ QoL utility measures were derived from the five-level EuroQoL five-dimensional (EQ-5D-5L) questionnaires completed by 11683 ASCEND participants (76% of 15480 recruited). EQ-5D utility decrements associated with cardiovascular (myocardial infarction, coronary revascularisation, transient ischaemic attack (TIA), ischaemic stroke, heart failure), bleeding (gastrointestinal (GI) bleed, intracranial haemorrhage, other major bleed), cancer (GI tract cancer, non-GI tract cancer), and microvascular events (end-stage renal disease (ESRD), amputation) were estimated using linear regression model following adjustment for participants’ socio-demographic and clinical risk factors. Results Amputation was associated with the largest EQ-5D utility decrement (-0.206), followed by heart failure (-0.185), intracranial haemorrhage (-0.164), GI bleed (-0.091), other major bleed (-0.096), ischaemic stroke (-0.061), TIA (-0.057), and non-GI tract cancer (-0.026). We were unable to detect decrements in EQ-5D utility associated with myocardial infarction, coronary revascularisation, GI tract cancer or ESRD. EQ-5D utility was lower at older age, independent of other factors. Conclusion These estimated decrements in QoL associated with cardiovascular, bleeding, cancer and other adverse events can inform assessments of overall value of treatments in patients with diabetes.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Supplementary materials, pdf, 602.4KB, Terms of use)
-
(Preview, Version of record, pdf, 1.2MB, Terms of use)
-
- Publisher copy:
- 10.1111/dom.14610
- Publisher:
- Wiley
- Journal:
- Diabetes, Obesity and Metabolism More from this journal
- Volume:
- 24
- Issue:
- 3
- Pages:
- 530-538
- Publication date:
- 2021-12-06
- Acceptance date:
- 2021-12-01
- DOI:
- EISSN:
-
1463-1326
- ISSN:
-
1462-8902
- Language:
-
English
- Keywords:
- Pubs id:
-
1221870
- Local pid:
-
pubs:1221870
- Deposit date:
-
2021-12-06
Terms of use
- Copyright holder:
- Keng et al.
- Copyright date:
- 2021
- Rights statement:
- © 2021 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record